Burning Rock Biotech Ltd
NASDAQ:BNR

Watchlist Manager
Burning Rock Biotech Ltd Logo
Burning Rock Biotech Ltd
NASDAQ:BNR
Watchlist
Price: 3.5591 USD 5.14% Market Closed
Market Cap: 38.3m USD

Relative Value

The Relative Value of one BNR stock under the Base Case scenario is 20.2504 USD. Compared to the current market price of 3.5591 USD, Burning Rock Biotech Ltd is Undervalued by 82%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BNR Relative Value
Base Case
20.2504 USD
Undervaluation 82%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
90
vs Industry
87
Median 3Y
1.3
Median 5Y
3.5
Industry
7.2
Forward
0.2
vs History
vs Industry
Median 3Y
-1.4
Median 5Y
-2.2
Industry
23.2
Forward
-3.6
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-4.7
Industry
19.3
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-4.6
Industry
22.5
vs History
90
vs Industry
67
Median 3Y
0.9
Median 5Y
1.7
Industry
2.7
vs History
vs Industry
86
Median 3Y
0.2
Median 5Y
1.7
Industry
7.5
Forward
-0.2
vs History
vs Industry
83
Median 3Y
0.2
Median 5Y
2.5
Industry
9.4
vs History
3
vs Industry
28
Median 3Y
-0.1
Median 5Y
-1.2
Industry
4.6
vs History
3
vs Industry
26
Median 3Y
-0.1
Median 5Y
-1.2
Industry
4.5
Forward
0.5
vs History
3
vs Industry
23
Median 3Y
-0.3
Median 5Y
-2.3
Industry
4.9
vs History
3
vs Industry
19
Median 3Y
-0.3
Median 5Y
-2.3
Industry
3.7
vs History
vs Industry
73
Median 3Y
0.2
Median 5Y
1.6
Industry
4.9

Multiples Across Competitors

BNR Competitors Multiples
Burning Rock Biotech Ltd Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Burning Rock Biotech Ltd
NASDAQ:BNR
38.3m USD 0.5 -1.2 0.9 0.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 536 021.3 -164 144.6 -199 323.9 -197 049.4
US
Abbvie Inc
NYSE:ABBV
327.6B USD 5.7 78.8 15.1 22.3
US
Amgen Inc
NASDAQ:AMGN
156B USD 4.6 26.3 14.2 23.4
US
Gilead Sciences Inc
NASDAQ:GILD
134.5B USD 4.7 22.5 9.8 13.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113.6B USD 10.2 -114.9 24.4 25.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 039.9 -520.5 -566.8 -551.7
AU
CSL Ltd
ASX:CSL
116B AUD 4.9 27.3 16.9 21.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
55.1B USD 3.9 12.2 10.8 12.2
US
Seagen Inc
F:SGT
39.3B EUR 19.6 -60.3 -64.9 -58.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
40.2B USD 17.1 -149.2 -668 -334.8
P/E Multiple
Earnings Growth PEG
CN
Burning Rock Biotech Ltd
NASDAQ:BNR
Average P/E: 33.4
Negative Multiple: -1.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -164 144.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
78.8
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.3
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.5
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -114.9 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -520.5 N/A N/A
AU
CSL Ltd
ASX:CSL
27.3
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.2
7%
1.7
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -149.2 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Burning Rock Biotech Ltd
NASDAQ:BNR
Average EV/EBITDA: 13.2
0.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -199 323.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.1
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.2
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
9.8
6%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.4
17%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -566.8 N/A N/A
AU
CSL Ltd
ASX:CSL
16.9
11%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
10.8
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -64.9 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -668 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Burning Rock Biotech Ltd
NASDAQ:BNR
Average EV/EBIT: 17
0.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 049.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.3
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.4
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.6
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.5
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -551.7 N/A N/A
AU
CSL Ltd
ASX:CSL
21.1
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.2
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -334.8 N/A N/A